Abstract
The transcription factor glioma-associated antigen-1 (Gli-1) mediates activation of the sonic hedgehog (Shh) pathway, a process that precedes the transformation of tissue stem cells into cancerous stem cells and that is involved in early and late epithelial tumorigenesis. Hypothesizing that targeting the 3′-untranslated region (3′-UTR) of Gli-1 mRNA would effectively inhibit epithelial tumor cell proliferation, we evaluated several complementary miRNA molecules for their ability to do so. The synthetic miRNAs and corresponding duplex/small temporal RNAs were introduced as 3-nucleotide (nt) loops into GU-rich portions of the 3′UTR Gli-1 sequence. One particular miRNA (miRNA Gli-1-3548) and its corresponding duplex (Duplex 3548) significantly inhibited proliferation of Gli-1+ ovarian (SK-OV-3) and pancreatic (MiaPaCa-2) tumor cells by delaying cell division and activating late apoptosis in MiaPaCa-2 cells. Here, we describe the design of effective miRNA sequences and their applications as anti-gene agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chu C.Y. and Rana T.M. (2007) Small RNAs: Regulators and guardians of the genome. J. Cell. Physiol. 213: 412–419.
Calin G.A. and Croce C.M. (2007) Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 117: 2059–2066.
Fabbri M., Ivan M., Cimmino A., Negrini M., and Calin G.A. (2007) Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin. Biol. Ther. 7: 1009–1019.
Kirino Y. and Mourelatos Z. (2007) Mouse Piwi-interacting RNAs are 2. ′-O-methylated at their 3′ termini Nat. Struct. Mol. Biol. 14: 259–260.
Thakur C.S., Jha B.K., Dong B., Das Gupta J., Silverman K.M., Mao H., Sawai H., Nakamura A.O., Banerjee A.K., Gudkov A., and Silverman R.H. (2007) Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc. Natl. Acad. Sci. U S A 104: (23)9585–9590.
Tsuda N., Chang D.Z., Mine T., Efferson C., García-Sastre A., Wang X., Ferrone S., and Ioannides C.G. (2007) Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells. Cancer Research 67: (17)8378–8387.
Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., Bertin S.L., Reppen T.W., Chu Q., Blokhin A.V., Hagstrom J.E., and Wolff J.A. (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U S A 104: (32)12982–12997.
Wightman B., Ha I., and Ruvkun G. (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: (5)855–862
Olsen P.H. and Ambros V. (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans. by blocking LIN-14 protein synthesis after the initiation of translation Dev. Biol. 216: 671–680.
Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., and Croce C.M. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U S A 101: 2999–3004.
Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838.
Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M.J., Tuschl T., and Margalit H. (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33: 2697–2706.
Hatfield S.D., Shcherbata H.R., Fischer K.A., Nakahara K., Carthew R.W., and Ruohola-Baker H. (2005) Stem cell division is regulated by the microRNA pathway. Nature 435: 974–978.
Sanchez P., Hernández A.M., Stecca B., Kahler A.J., DeGueme A.M., Barrett A., Beyna M., Datta M.W., Datta S., Ruiz I., and Altaba A. (2004) Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc. Natl. Acad. Sci. U S A 101: 12561–12566.
Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernández-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., and Hebrok M. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851–856.
Frank-Kamenetsky M., Zhang X.M., Bottega S., Guicherit O., Wichterle H., Dudek H., Bumcrot D., Wang F.Y., Jones S., Shulok J., Rubin L.L., and Porter J.A. (2002) Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J. Biol. 1: 10.
Stecca B., Ruiz I., and Altaba A. (2002) The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway. J. Biol. 1: 9.
Groom J.R., Fletcher C.A., Walters S.N., Grey S.T., Watt S.V., Sweet M.J., Smyth M.J., Mackay C.R., and Mackay F. (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J. Exp. Med. 204: 1959–1971.
Chen X.M., Splinter P.L., O’Hara S.P., and LaRusso N.F. (2007) A cellular miRNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem. 282: 28929–28938.
Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., and Akira S. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101–105.
Hornung V., Ellegast J., Kim S., Brzózka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., and Hartmann G. (2006) 5. ′-Triphosphate RNA is the ligand for RIG-I Science 314: 994–997.
Iordanov M.S., Paranjape J.M., Zhou A., Wong J., Williams B.R., Meurs E.F., Silverman R.H., and Magun B.E. (2000) Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol Cell Biol. 20: 617–627.
Malathi K., Dong B., Gale M., and Jr.Silverman R.H. (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816–819.
Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., and Karin M. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121–124.
Rakoff-Nahoum S. and Medzhitov R. (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124–127.
Onoguchi K., Yoneyama M., Takemura A., Akira S., Taniguchi T., Namiki H., and Fujita T. (2007) Viral infections activate types I and III interferon genes through a common mechanism. J. Biol. Chem. 282: 7576–7581.
Tsuda N., Kawano K., Efferson C.L., and Ioannides C.G. (2005) Synthetic microRNA and double-stranded RNA targeting the 3. ′-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells Int. J. Oncol. 27: 1299–1306
Tsuda N., Ishiyama S., Li Y., Ioannides C.G., Abbruzzese J.L., and Chang D.Z. (2006) Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells. Clin .Cancer Res. 12: 6557–6564.
Doench J.G., Petersen C.P., and Sharp P.A. (2003) siRNAs can function as miRNAs. Genes Dev. 17: 438–442.
Doench J.G. and Sharp P.A. (2004) Specificity of microRNA target selection in translational repression. Genes Dev. 18: 504–511.
Scacheri P.C., Rozenblatt-Rosen O., Caplen N.J., Wolfsberg T.G., Umayam L., Lee J.C., Hughes C.M., Shanmugam K.S., Bhattacharjee A., Meyerson M., and Collins F.S. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101: 1892–1897.
Efferson C.L., Tsuda N., Kawano K., Nistal-Villán E., Sellappan S., Yu D., Murray J.L., García-Sastre A., and Ioannides C.G. (2006) Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J. Virol. 80: 383–394.
Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., and Tuschl T. (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20: 6877–6888.
Zuker M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406–3415.
Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. (2003) Prediction of Mammalian MicroRNA Targets. Cell 115: 787–798
Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., and Kellis M. (2005) Systematic discovery of regulatory motifs in human promoters and 3. ′ UTRs by comparison of several mammals Nature 434: 338–345
Acknowledgements
This work has been supported in part by the Topfer Pancreatic Cancer Research Fund (DZC, NT), Grant DOD-01-1-299 (CGI, NT), and grant from the 21st Century COE program from the Kurume University (NT, TM).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tsuda, N., Mine, T., Ioannides, C., Chang, D. (2009). Synthetic microRNA Targeting Glioma-associated Antigen-1 Protein. In: Sioud, M. (eds) siRNA and miRNA Gene Silencing. Methods in Molecular Biology, vol 487. Humana Press. https://doi.org/10.1007/978-1-60327-547-7_21
Download citation
DOI: https://doi.org/10.1007/978-1-60327-547-7_21
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-546-0
Online ISBN: 978-1-60327-547-7
eBook Packages: Springer Protocols